Latest Polyclonal B cell response Stories
The immune system is a vital part of our defenses against pathogens, but it can also attack host tissues, resulting in autoimmune disease.
In a major shake-up of scientists' understanding of what determines the fate of cells, researchers at the Walter and Eliza Hall Institute have shown that cells have some control over their own destiny.
Scientists at Johns Hopkins have taken a less-is-more approach to designing effective drug treatments that are precisely tailored to disease-causing pathogens, such as viruses and bacteria, and cancer cells, any of which can trigger the body's immune system defenses.
EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies â€“ the proteins produced in the blood which counteract bacteria, viruses or cancerous cells.